Stephen Elliman

Company: Orbsen Therapeutics

Job title: Chief Scientific Officer

Seminars:

Systemic Cell Therapy in Early Phase Trials for Diabetic Kidney Disease 10:30 am

Showcasing successful demonstration of feasibility, safety and preliminary efficacy of allogeneic cell therapy for Progressive CKD in a phase 1/2 trial setting Setting the scene for Phase 3 trials in US, Japan & EU Evaluating how close this is to widespread commercial/ clinical realityRead more

day: Day 2 Track 2 AM